Use of 5-fluorouracil, epirubicin and mitomycin C (FEM) as adjuvant therapy in node-positive, radically-resected gastric cancer patients: survey of a general hospital experience. - Caffo O; Ambrosini G; Amichetti M; Brugnara S; Graiff C; Robbiati SF; Galligioni E (Oncology reports, 1998)